Lv2
140 积分 2023-10-22 加入
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma
20天前
已完结
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
20天前
已完结
Application of Neoadjuvant Docetaxel Plus Cisplatin in Early-Stage Triple-Negative Breast Cancer (HELEN-001): Results from a Phase II Trial
24天前
已完结
Peripheral neuropathy: from guidelines to clinical practise
1个月前
已完结
Safety and Efficacy of Trastuzumab Deruxtecan for Metastatic HER2+ and HER2-low Breast Cancer
2个月前
已完结
Understanding the Spectrum of HER2 Status in Breast Cancer: From HER2-Positive to Ultra-Low HER2
2个月前
已完结
Global patterns and trends in breast cancer incidence and mortality across 185 countries
2个月前
已完结
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Borderline Indications for Ovarian Suppression: Addressing Uncertainties with Patients
2个月前
已关闭
Borderline Indications for Ovarian Suppression: Addressing Uncertainties with Patients
2个月前
已关闭
皖公网安备34019202002308
